Hepion Historical Valuation

HEPA Stock  USD 0.48  0.13  21.31%   
Some fundamental drivers such as market cap or Hepion Pharmaceuticals enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Hepion Pharmaceuticals valuation indicators such as Enterprise Value of 1.2 B to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Hepion Pharmaceuticals's future value.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hepion Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.

About Hepion Valuation Data Analysis

Valuation is the financial process of determining what Hepion Pharmaceuticals is worth. Hepion Pharmaceuticals valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Hepion Pharmaceuticals valuation ratios help investors to determine whether Hepion Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hepion with respect to the benefits of owning Hepion Pharmaceuticals security.

Hepion Pharmaceuticals Valuation Data Chart

As of March 30, 2025, Market Cap is expected to decline to about 1.3 B. In addition to that, Enterprise Value is expected to decline to about 1.2 B

Enterprise Value

Enterprise Value (or EV) is usually referred to as Hepion Pharmaceuticals theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Hepion Pharmaceuticals debt, but would also pocket its cash. Enterprise Value is more accurate representation of Hepion Pharmaceuticals value than its market capitalization because it takes into account all of Hepion Pharmaceuticals existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Hepion Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hepion Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hepion Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hepion Pharmaceuticals Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hepion Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hepion Pharmaceuticals. If investors know Hepion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hepion Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(220.00)
Return On Assets
(1.10)
Return On Equity
(2.88)
The market value of Hepion Pharmaceuticals is measured differently than its book value, which is the value of Hepion that is recorded on the company's balance sheet. Investors also form their own opinion of Hepion Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Hepion Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hepion Pharmaceuticals' market value can be influenced by many factors that don't directly affect Hepion Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hepion Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hepion Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hepion Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.